These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20711079)

  • 41. Invasive candidiasis: from mycobiome to infection, therapy, and prevention.
    Lagunes L; Rello J
    Eur J Clin Microbiol Infect Dis; 2016 Aug; 35(8):1221-6. PubMed ID: 27146877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human inborn errors of immunity underlying superficial or invasive candidiasis.
    Puel A
    Hum Genet; 2020 Jun; 139(6-7):1011-1022. PubMed ID: 32124012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Invasive candidiasis: new insights presaging new therapeutic approaches?
    Pepys MB
    J Infect Dis; 2012 Nov; 206(9):1339-41. PubMed ID: 22927458
    [No Abstract]   [Full Text] [Related]  

  • 44. Candida and host determinants of susceptibility to invasive candidiasis.
    Lionakis MS; Netea MG
    PLoS Pathog; 2013 Jan; 9(1):e1003079. PubMed ID: 23300452
    [No Abstract]   [Full Text] [Related]  

  • 45. New features of invasive candidiasis in humans: amyloid formation by fungi and deposition of serum amyloid P component by the host.
    Gilchrist KB; Garcia MC; Sobonya R; Lipke PN; Klotz SA
    J Infect Dis; 2012 Nov; 206(9):1473-8. PubMed ID: 22802434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [7th Greifswalder Mycology Colloquium. Candida as normal flora and a pathogen. Greifswald, Germany, 29-30 January 1999. Proceedings].
    Mycoses; 1999; 42 Suppl 1():1-79. PubMed ID: 10627196
    [No Abstract]   [Full Text] [Related]  

  • 47. [Invasive fungal disease by Candida and other yeasts].
    Pemán J; Salavert M; Quindós G
    Rev Iberoam Micol; 2016; 33(3):131-2. PubMed ID: 27296910
    [No Abstract]   [Full Text] [Related]  

  • 48. The Pathophysiology and Treatment of Candida Sepsis.
    Spellberg B; Edwards JE
    Curr Infect Dis Rep; 2002 Oct; 4(5):387-399. PubMed ID: 12228025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Candida infections in severe acute pancreatitis: we need to do more in order to distinguish invasive infection from simple colonization.
    Honore PM; Mugisha A; Kugener L; Redant S; Attou R; Gallerani A; De Bels D
    Crit Care; 2020 Apr; 24(1):156. PubMed ID: 32299462
    [No Abstract]   [Full Text] [Related]  

  • 50. Understanding the role of host immune responses in invasive candidiasis.
    Desai JV; van de Veerdonk FL; Lionakis MS
    Intensive Care Med; 2018 Aug; 44(8):1310-1314. PubMed ID: 29167916
    [No Abstract]   [Full Text] [Related]  

  • 51. Appropriate Treatment of Invasive Candidiasis in ICU: Timing, Colonization Index, Candida Score & Biomarkers, Towards de-Escalation?
    De Rosa FG; Corcione S; Montrucchio G; Brazzi L; Di Perri G
    Turk J Anaesthesiol Reanim; 2016 Dec; 44(6):279-282. PubMed ID: 28058136
    [No Abstract]   [Full Text] [Related]  

  • 52. Fatty acids and derivatives as antimicrobial agents.
    Kabara JJ; Swieczkowski DM; Conley AJ; Truant JP
    Antimicrob Agents Chemother; 1972 Jul; 2(1):23-8. PubMed ID: 4670656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Probiotics as Antifungals in Mucosal Candidiasis.
    Matsubara VH; Bandara HM; Mayer MP; Samaranayake LP
    Clin Infect Dis; 2016 May; 62(9):1143-53. PubMed ID: 26826375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism.
    Kennedy MJ; Volz PA
    Infect Immun; 1985 Sep; 49(3):654-63. PubMed ID: 3897061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thermal degradation of sucralose: a combination of analytical methods to determine stability and chlorinated byproducts.
    de Oliveira DN; de Menezes M; Catharino RR
    Sci Rep; 2015 Apr; 5():9598. PubMed ID: 25873245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Can Lactobacillus fermentum LF10 and Lactobacillus acidophilus LA02 in a slow-release vaginal product be useful for prevention of recurrent vulvovaginal candidiasis?: A clinical study.
    Murina F; Graziottin A; Vicariotto F; De Seta F
    J Clin Gastroenterol; 2014; 48 Suppl 1():S102-5. PubMed ID: 25291115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors influencing the growth of Candida albicans (in vivo and in vitro studies).
    Cormane RH; Goslings WR
    Sabouraudia; 1963 Oct; 3(1):52-63. PubMed ID: 5336692
    [No Abstract]   [Full Text] [Related]  

  • 58. Curcumin as a promising anticandidal of clinical interest.
    Neelofar K; Shreaz S; Rimple B; Muralidhar S; Nikhat M; Khan LA
    Can J Microbiol; 2011 Mar; 57(3):204-10. PubMed ID: 21358761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulating effect of dietary carbohydrate supplementation on Candida albicans colonization and invasion in a neutropenic mouse model.
    Vargas SL; Patrick CC; Ayers GD; Hughes WT
    Infect Immun; 1993 Feb; 61(2):619-26. PubMed ID: 8423091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sucralose, a synthetic organochlorine sweetener: overview of biological issues.
    Schiffman SS; Rother KI
    J Toxicol Environ Health B Crit Rev; 2013; 16(7):399-451. PubMed ID: 24219506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.